Developability and Early CMC Development

PineTree Therapeutics is an innovative biotech company pioneering multispecific degrader antibodies to revolutionize cancer treatment. We are seeking a Director to provide scientific and strategic leadership in early CMC development. This individual will oversee the development of late-stage drug candidates with analytical and developability screening and cell line development. The ideal candidate will have extensive experience in analytical method development, developability assessment, lead selection, and expertise in managing internal resources alongside external CROs. Responsibilities include establishing analytical methods, collaborating with cross-functional teams, leading CMC strategies, and managing relationships with external partners. Qualifications include a PhD or advanced degree, 10+ years of experience in CMC development, and strong interpersonal and problem-solving skills.